GeNeuro appoints new Chief Medical Officer

(CercleFinance.com) - GeNeuro announces the appointment of Anke Post as Chief Medical Officer, effective last Friday, following the retirement of David Leppert, who had held this position since April 2020.


Following his retirement, David Leppert will continue to support the biopharmaceutical company as a consultant in its mission to introduce temelimab to multiple sclerosis patients.

Anke Post brings to GeNeuro her experience in neuroscience, psychiatry and neurology, as well as in the pharmaceutical industry. She has held senior positions at Novartis, Eli Lilly and Roche.

Copyright (c) 2024 CercleFinance.com. All rights reserved.